Farallon Capital Management 13F: Adds $15M to THC Stake

Farallon Capital Boosts Tenet Healthcare Position

Farallon Capital Management lifted its investment in Tenet Healthcare Corporation NYSE THC during the period, according to a Form 13F filing filed with the Securities and Exchange Commission. The fund grew its position by a 21.5% increase, purchasing an additional 80,000 shares. That purchase brought its total holdings to 452,153 shares. At the close of the reporting window, that block of stock carried a reported value of about $84.6 million. Because 13F filings look backward at past quarters, this snapshot shows the fund's holdings as of May 15, 2026, and may not reflect its current position.

Tenet Healthcare Stock Trades Below Moving Averages

Shares of Tenet Healthcare changed hands around $187.08 as the broader market finished the week. The healthcare provider's stock trades below its 50-day moving average of $250.51 and its 200-day moving average of $211.09, sitting within a 52-week trading range spanning from $157.58 to $283.05. The company posts a price-to-earnings ratio of 10.1 alongside a forward P/E ratio of 12.4, backed by a market capitalization of roughly $21.01 billion.

Recent Earnings Highlight Profitability

Tenet Healthcare reported solid financial performance in its latest results, showing $21.81 billion in revenue alongside a revenue growth rate of 6.8%. The operator of general hospitals and ambulatory surgery centers achieved an earnings per share figure of $25.86, paired with a net margin of 10.3% and a return on equity of 37.3%. Investors tracking the healthcare provider will look toward the upcoming earnings release on October 27, 2026, for updated financial results and operational updates.

Wall Street Analysts Review Targets

Wall Street firms keep a close eye on the medical care facilities operator, holding a strong buy recommendation key backed by 21 analyst opinions. On October 16, 2026, Guggenheim maintained its buy rating and set a $307 price target, stepping up from its earlier $283 target on July 28, 2026. Earlier on September 23, 2026, BMO Capital initiated coverage with a market perform rating and a $265 target, while Leerink Partners kept an outperform rating with a $309 target on September 18, 2026. Wells Fargo maintained an overweight rating on August 3, 2026, raising its target to $281 from $231, and Truist Securities kept a buy rating on July 28, 2026, with a $290 target. Baird also kept a neutral rating on July 28, 2026, raising its target to $280, and UBS kept a buy rating on July 27, 2026, raising its target to $308.

Healthcare Provider Operations in Texas

Headquartered in Dallas, Texas, Tenet Healthcare operates as a diversified healthcare services company across the United States. The enterprise runs general hospitals offering acute care, surgical robotic access, and intensive care units, alongside an extensive network of ambulatory surgery centers, imaging facilities, and micro-hospitals. The company employs roughly 77,000 workers across its hospital operations and ambulatory care segments.

Watching Institutional Flows and Filings

Institutional investors continue to adjust their stakes in the healthcare provider, as seen when Lone Pine Capital increased its stake in Tenet Healthcare by over 26% in its own recent filing. Future SEC filings will also show whether Farallon Capital Management continues to expand its position or takes profits following the latest quarter. Market participants will monitor upcoming disclosures and the October earnings report for further clarity on institutional sentiment.